Pancreatic cancer remains one of the most difficult cancers to treat, in large part because tumors do not exist in isolation.

New research has identified a protein that could serve as both a biomarker and therapeutic target to weaken stem-like cancer ...

Activation of a specific part of the Dicer enzyme can change its shape in a way that affects its critical role in proper cell ...

Activation of a specific part of the Dicer enzyme can change its shape in a way that affects its critical role in proper cell ...

Artificial intelligence (AI) is emerging as a powerful force in breast cancer research, but the future of personalized care ...

We need investment in precision medicine technologies to start programming cancer against itself, writes Cyriac Roeding.

A new review from the Icahn School of Medicine at Mount Sinai and the Hospital Clínic de Barcelona provides one of the clearest roadmaps to date for understanding and treating liver cancer, one of the ...

Researchers at VIB and VUB have developed a powerful new way to study how the immune system behaves inside lung tumors. By combining a patient-relevant mouse model with single-cell technologies, the ...

WHAT: Researchers from the Johns Hopkins Kimmel Cancer Center will present new research findings and receive honors and ...

The body’s “killer” T cells don’t just attack—they strike with astonishing precision, forming a tiny, highly organized ...

Fundamental research into the mechanisms behind cancers at an institution in Japan is leading to new approaches for tackling these notoriously complex diseases. Every year, up to 20 million people in ...